Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
131I-LNTH-1095 Radioligand Therapy plus Enzalutamide versus Enzalutamide Alone in Men with PSMA-Avid Metastatic Castration-Resistant Prostate Cancer: A Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 27, 2025
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.
Journal: Nature communications
Published: September 22, 2025
Genes Encoding Multiple Modulators of the Immune Response Are Methylated in the Prostate Tumor Microenvironment of African Americans.
Journal: Cancers
Published: May 22, 2025
Phase II Trial of Opaganib Addition in Metastatic Castration-Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide.
Journal: Cancer medicine
Published: January 27, 2025
Ceramide-Induced Metabolic Stress Depletes Fumarate and Drives Mitophagy to Mediate Tumor Suppression.
Journal: Cancer research
Published: October 28, 2024
A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients.
Journal: Clinical and translational medicine
Published: November 17, 2023
Mediator kinase inhibition reverses castration resistance of advanced prostate cancer.
Journal: The Journal of clinical investigation
Published: October 24, 2023
Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer.
Journal: Frontiers in oncology
Published: April 07, 2023
Racial Distribution of Neighborhood-Level Social Deprivation in a Retrospective Cohort of Prostate Cancer Survivors.
Journal: Diseases (Basel, Switzerland)
Published: August 13, 2022
Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA.
Journal: Frontiers in oncology
Published: June 11, 2022
Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis.
Journal: Cell reports
Published: February 02, 2022
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race.
Journal: The oncologist
Published: January 20, 2022
Last Updated: 09/26/2026